FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.4  |  FHIR Version n/a  User: [n/a]

1464651000168104: Nucala (mepolizumab 100 mg / 1 mL) injection, 1 mL syringe (trade product unit of use)

Status: current, Defined. Date: 31-May 2020. Module: Australian Medicines Terminology module

Descriptions:

Id Description Lang Type Status Case? Module
4389511000168117 Nucala (mepolizumab 100 mg / 1 mL) injection, 1 mL syringe (trade product unit of use) en Fully specified name Active Case sensitive Australian Medicines Terminology module
4389521000168112 Nucala 100 mg/mL injection, 1 mL syringe en Synonym Active Case sensitive Australian Medicines Terminology module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Nucala 100 mg/mL injection, 1 mL syringe Is a mepolizumab 100 mg/mL injection, syringe true Inferred relationship Some
Nucala 100 mg/mL injection, 1 mL syringe Is a trade product unit of use true Inferred relationship Some
Nucala 100 mg/mL injection, 1 mL syringe Is a Nucala true Inferred relationship Some
Nucala 100 mg/mL injection, 1 mL syringe has manufactured dose form injection true Inferred relationship Some
Nucala 100 mg/mL injection, 1 mL syringe has intended active ingredient mepolizumab true Inferred relationship Some 811979188
Nucala 100 mg/mL injection, 1 mL syringe has Australian BoSS mepolizumab true Inferred relationship Some 811979188
Nucala 100 mg/mL injection, 1 mL syringe has unit of use syringe true Inferred relationship Some 435743214
Inbound Relationships Type Active Source Characteristic Refinability Group
Nucala 100 mg/mL injection, 1 mL syringe has TPUU True Nucala 100 mg/mL injection, 1 mL syringe Inferred relationship Some 54636256
Nucala 100 mg/mL injection, 1 mL syringe has TPUU True Nucala 100 mg/mL injection, 1 mL syringe Inferred relationship Some 32020447

Reference Sets

Trade product unit of use reference set

Back to Start